Medical Policies and Guidelines for Multiple myeloma not having achieved remission

Related policies from health plans

Bendamustine Hydrochloride
Darzalex (daratumumab)
Denosumab agents
Empliciti (elotuzumab)
Kyprolis (carfilzomib)
Mozobil (plerixafor)
Sarclisa (isatuximab-irfc)
Tecvayli (teclistamab-cqyv)
Therapeutic Apheresis
Velcade (bortezomib)
Zoledronic Acid Agents

Similar Codes